Reversing antibiotic resistance? Here’s how Sweden is doing it

Dr Mina Bakhit, Prof Chris Del Mar, & Helena Kornfält Isberg, MD

writer

Dr Mina Bakhit, Prof Chris Del Mar, & Helena Kornfält Isberg, MD

Postdoctoral Research Fellow, Bond University | Professor of Public Health, Bond University | General practitioner, PhD-student, Lund University

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

The antibiotic resistance threat is real. In the years to come, we will no longer be able to treat and cure many infections we once could.

We’ve had no new classes of antibiotics in decades, and the development pipeline is largely dry. Each time we use antibiotics, the bacteria in our bodies become more resistant to the few antibiotics we still have.

The problem seems clear and the solution obvious: to prescribe our precious antibiotics only when absolutely needed. Implementing this nationally is not an easy task. But Australia could take cues from other countries making significant progress in this area, such as Sweden.

The Swedish example

Antibiotic use was rising steadily in Sweden during the 1980s and 1990s, causing an increase in antibiotic resistant bacteria. A group of doctors mobilised to tackle this threat, and brought together peak bodies across pharmaceuticals, infectious diseases and other relevant areas to form a national coalition.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Genitourinary Syndrome of Menopause – Mythbusting for GPs

Prof Sonia Grover

Prof Sonia Grover

Dysmenorrhoea in Teens

Prof Paul Griffin

Prof Paul Griffin

Winter Virus Preparations

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Mina Bakhit, Prof Chris Del Mar, & Helena Kornfält Isberg, MD

writer

Dr Mina Bakhit, Prof Chris Del Mar, & Helena Kornfält Isberg, MD

Postdoctoral Research Fellow, Bond University | Professor of Public Health, Bond University | General practitioner, PhD-student, Lund University

Test your knowledge

Recent articles

Latest GP poll

"I am concerned about disrupted continuity of care for patients that use 1800Medicare"

Strongly agree

0%

Slightly agree

0%

Slightly disagree

0%

Strongly disagree

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease